The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(3-(4-Fluorophenyl)-5-methyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)-1,3,4-oxathiazol-2-one ID: ALA4483550
PubChem CID: 155540804
Max Phase: Preclinical
Molecular Formula: C20H10FNO5S
Molecular Weight: 395.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(-c2nsc(=O)o2)c(=O)oc2cc3occ(-c4ccc(F)cc4)c3cc12
Standard InChI: InChI=1S/C20H10FNO5S/c1-9-12-6-13-14(10-2-4-11(21)5-3-10)8-25-15(13)7-16(12)26-19(23)17(9)18-22-28-20(24)27-18/h2-8H,1H3
Standard InChI Key: WOSWSUPINGDEAI-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
5.9743 -13.8826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6799 -13.4757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6811 -12.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9725 -12.2453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2675 -12.6526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2662 -13.4737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4850 -13.7261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0033 -13.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4869 -12.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3924 -12.2367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1070 -12.6526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1059 -13.4778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3900 -13.8870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8122 -12.2490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5580 -12.5831 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1063 -11.9772 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.6994 -11.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8997 -11.4365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3924 -11.4195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8124 -13.8883 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0335 -10.5227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2361 -11.6232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7856 -11.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5348 -10.2399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7350 -10.0681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1864 -10.6795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4401 -11.4541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4826 -9.2909 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
3 2 1 0
3 4 2 0
4 5 1 0
6 5 2 0
6 1 1 0
7 6 1 0
8 7 1 0
9 8 2 0
5 9 1 0
3 10 1 0
11 10 2 0
12 11 1 0
13 12 1 0
2 13 1 0
11 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
10 19 1 0
12 20 2 0
17 21 2 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
9 22 1 0
25 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 395.37Molecular Weight (Monoisotopic): 395.0264AlogP: 4.73#Rotatable Bonds: 2Polar Surface Area: 86.45Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.82CX LogD: 4.82Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.40Np Likeness Score: -0.57
References 1. Schiffrer ES, Sosič I, Šterman A, Mravljak J, Raščan IM, Gobec S, Gobec M.. (2019) A focused structure-activity relationship study of psoralen-based immunoproteasome inhibitors., 10 (11): [PMID:32952997 ] [10.1039/C9MD00365G ]